In addition to its treatment for a progressive form of blindness, the company has also been testing a way to combat hemophilia B, a blood clotting disorder, by intravenous treatment with viruses ...
PHILADELPHIA.Today on MSN3mon
Former CHOP CEO, Spark Therapeutics Co-founder To Lead New Biotech Startup After Receiving $54M in FundingDr. Steven M. Altschuler, who served 15 years as CEO of The Children’s Hospital of Philadelphia and is the co-founder of ...
Spark Therapeutics’ merger with Roche has moved a step closer after the UK’s competition watchdog okayed the $4.8 billion deal, ahead of a regulatory deadline later today in the US.
Shareholders in Spark Therapeutics haven’t been queueing up to take advantage of Roche’s $114.50-per-share offer, forcing an extension to the tender process. Roche said this week that it plans ...
Dyno also counts Sarepta Therapeutics and Astellas among its partners. Roche made a big commitment to gene therapies with its $4.3 billion acquisition of Luxturna maker Spark Therapeutics in 2019.
who was a former scientific founder of Spark Therapeutics and will join the board of the new Opus. As part of the deal, Ocuphire is offloading a clinical-stage candidate in the form of APX3330 ...
Science 2019-09-10T14:49:00Z $4.8 billion biotech Spark Therapeutics had to find a way to prove its first-of-its-kind treatment for eye disease actually worked. We got the inside story on how it ...
Perspective Therapeutics, Inc. ( (CATX) ) has released its Q3 earnings. Here is a breakdown of the information Perspective Therapeutics, Inc.
Victoria Nash - Drexel Graduate Co-op at Spark Therapeutics (1/3) Victoria Nash - Advice for Graduate Students in Biomedical Engineering (2/3) Victoria Nash - Benefits of Drexel Biomedical Engineering ...
Today, at least 11 companies are producing experimental or clinically-approved rAAV-based therapies using this approach, including Spark Therapeutics’ Luxturna and a pair of other therapies now ...
Werewolf Therapeutics ( (HOWL) ) just unveiled an update. Werewolf Therapeutics is pioneering the development of innovative cytokine therapies ...
Spark Therapeutics The company’s focus is on developing one-time, life-altering treatments for debilitating genetic diseases, a whole new model of personalized, precise treatment.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback